A recent study has found that dronabinol, a synthetic version of THC (the primary psychoactive component in cannabis), ...

Nearly seven million Americans are living with Alzheimer’s disease – a leading cause of death in the United States.

Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer's ...

“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the ...

There is also hope that our nation is finally beginning to make the dementia public health crisis a priority. Over the past ...

AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to ...

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...

Researchers suggest that the way Alzheimer's reshapes our brains is as unique as our fingerprints, challenging long-held ...

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.

In recent years, we have seen significant advances in the development of drugs to tackle Alzheimer’s, particularly in the wake of two decades of largely unfruitful research. Though some such ...

Summary: A new study finds that brain shrinkage in Alzheimer’s patients does not follow a uniform pattern. Researchers ...

Discovery may offer new therapeutic target for development of new drugs against Alzheimer's and other neurodegenerative disorders.